Fourth Annual Chicago Supportive Oncology Conference - October 15-18, 2008 - (Page 2)

October 15-18, 2008 �� PROGRAMOVERVIEW Cancer and its treatment continue to cause signiﬁcant pain and suffering for both patients who survive as well as for those who do not. For patients in palliative or end-of-life care, multiple concurrent physical and psychological symptoms are to blame. For many reasons, issues such as pain, fatigue, anorexia, loss of physical and/or cognitive function, depression, bone loss, sexual dysfunction, oral and/or gastrointestinal mucositis, and mood swings are frequently underassessed as well as undertreated. Because such side effects are responsible for diminished quality of life and may require treatment modiﬁcations that ultimately contribute to poorer outcomes and possibly shorter survival, these issues warrant supportive care. The Chicago Supportive Oncology Conference will offer attendees current perspectives on these and other palliative care concerns for patients with cancer and for the medical professionals who treat them. Not only does the meeting include overviews of toxicities associated with selected cancers and their therapies, it provides state-of-the-art management alternatives, guidelines for improving communication with patients, and key considerations in end-of-life care. LEARNINGOBJECTIVES After completing this activity, participants should be able to: Provide the rationale for integrating supportive and palliative care for patients with cancer earlier in the course of treatment and throughout the course of their disease Detect common skeletal-related complications of cancer and cancer therapy, new pathways for treatment of bone metastases, and management of treatment-related adverse events Recognize toxicities related to aggressive therapy, such as aromatase inhibitors and biologic therapies like IL-2 and EGFR inhibitors, mechanisms underlying these toxicities, and current strategies for their management State the effects that cancer and its treatment can have on psychosocial aspects of patient care, including depression and grief, as well as cognitive function Distinguish common treatment issues in breast cancer patients, such as sexual dysfunction with hormonal therapy and cardiotoxicity with anthracyclines and trastuzumab, and how best to prevent or manage these toxicities Identify novel approaches to improving cancer pain management, including use of opioids or analgesics for control of neuropathy and cytokine-based therapy Characterize symptoms seen in the post-transplant setting, such as late neurologic effects and GVHD, and current approaches for their management Deﬁne major treatment-related issues for patients with advanced head and neck cancer and approaches for integrating their management with overall oral care Restate current models of the mechanisms underlying cancer-related mucositis, constipation, and cachexia and list therapies targeting these pathways

Table of Contents Feed for the Digital Edition of Fourth Annual Chicago Supportive Oncology Conference - October 15-18, 2008

Fourth Annual Chicago Supportive Oncology Conference - October 15-18, 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.